David C. Montefiori

86.4k citations

616 papers · 33.7k indexed · 7 hit papers · h-index 92

Virology top 0.01%
Immunology top 0.02%
Infectious Diseases top 0.02%
Epidemiology top 0.05%
Molecular Biology top 0.5%

Co-authors: John R. Mascola Norman L. Letvin Barton F. Haynes Celia C. LaBranche Miroslawa Bilska Michael S. Seaman Jörn E. Schmitz William M. Mitchell
Topics: HIV Research and Treatment (545 papers)Immune Cell Function and Interaction (240 papers)HIV/AIDS drug development and treatment (116 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Nature Science New England Journal of Medicine
Partner nations: United States United Kingdom Netherlands

In The Last Decade

David C. Montefiori

603 papers receiving 33.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 ⁺ Lymphocytes

1999 1.8k citations Jörn E. Schmitz, Marcelo J. Kuroda et al. Science profile →
Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies

2005 845 citations John R. Mascola, Leonidas Stamatatos et al. Journal of Virology profile →
Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus Infection

1995 562 citations David C. Montefiori et al. profile →
Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

2002 544 citations Dan H. Barouch, Marcelo J. Kuroda et al. profile →
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies

2009 446 citations Michael S. Seaman, Natalie Hawkins et al. Journal of Virology profile →
A Bivalent Omicron-Containing Booster Vaccine against Covid-19

2022 346 citations David C. Montefiori et al. profile →
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines

2021 222 citations David C. Montefiori et al. profile →

Peers

Countries citing papers authored by David C. Montefiori

Since Specialization

Citations

This map shows the geographic impact of David C. Montefiori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Montefiori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Montefiori more than expected).

Fields of papers citing papers by David C. Montefiori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Montefiori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Montefiori. The network helps show where David C. Montefiori may publish in the future.

Co-authorship network of co-authors of David C. Montefiori

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Montefiori. A scholar is included among the top collaborators of David C. Montefiori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Montefiori. David C. Montefiori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain 2022 ·Science Advances ·Matthew D. Gray,Junli Feng,Connor Weidle,Kristen W. Cohen,Lamar Ballweber-Fleming,Anna J. MacCamy,(unknown),(unknown),David C. Montefiori,Guido Ferrari,Marie Pancera,M. Juliana McElrath,Leonidas Stamatatos	2
2	The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat 2021 ·Proceedings of the National Academy of Sciences ·David C. Montefiori,(unknown),(unknown),(unknown),Joseph G. Joyce,John W. Shiver,Celia C. LaBranche,Peter S. Kim	15
3	Frequent Development of Broadly Neutralizing Antibodies in Early Life in a Large Cohort of Children With Human Immunodeficiency Virus 2021 ·The Journal of Infectious Diseases ·(unknown),Youyi Fong,(unknown),Maria Dennis,Joshua Eudailey,Ashley N. Nelson,Kevin O. Saunders,Coleen K. Cunningham,Elizabeth J. McFarland,Ross E. McKinney,M. Anthony Moody,Celia C. LaBranche,David C. Montefiori,Sallie R. Permar,Genevieve G. Fouda	6
4	Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIV _AD8 in Rhesus Macaques: Implications for Use in Vaccine Studies 2012 ·Journal of Virology ·Rajeev Gautam,Yoshiaki Nishimura,W. Robert Lee,Olivia K. Donau,Alicia Buckler‐White,Masashi Shingai,Reza Sadjadpour,Stephen D. Schmidt,Celia C. LaBranche,Brandon F. Keele,David C. Montefiori,John R. Mascola,Malcolm A. Martin	35
5	Engineering, Expression, Purification, and Characterization of Stable Clade A/B Recombinant Soluble Heterotrimeric gp140 Proteins 2011 ·Journal of Virology ·George Sellhorn,Zane Kraft,Zachary Caldwell,(unknown),(unknown),Michael S. Seaman,David C. Montefiori,(unknown),Leonidas Stamatatos	26
6	Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses 2011 ·Journal of Virology ·Mark Melchers,Ilja Bontjer,Tommy Tong,Nancy P. Y. Chung,Per Johan Klasse,Dirk Eggink,David C. Montefiori,(unknown),Andrea Cerutti,William C. Olson,Ben Berkhout,James Μ. Binley,John P. Moore,Rogier W. Sanders	39
7	Immunization with Recombinant HLA Classes I and II, HIV-1 gp140, and SIV p27 Elicits Protection against Heterologous SHIV Infection in Rhesus Macaques 2011 ·Journal of Virology ·Andreas Mörner,Marianne Jansson,Evelien M. Bunnik,(unknown),R. S. Vaughan,Yufei Wang,David C. Montefiori,Ńel Otting,Ronald E. Bontrop,Lesley A. Bergmeier,Mahavir Singh,Richard T. Wyatt,Hanneke Schuitemaker,Gunnel Biberfeld,Rigmor Thorstensson,Thomas Lehner	14
8	Quaternary Epitope Specificities of Anti-HIV-1 Neutralizing Antibodies Generated in Rhesus Macaques Infected by the Simian/Human Immunodeficiency Virus SHIV _SF162P4 2010 ·Journal of Virology ·James E. Robinson,(unknown),Debra Elliott,(unknown),(unknown),David C. Montefiori,Susan Zolla‐Pazner,Miroslaw K. Górny,Zane Kraft,Leonidas Stamatatos	37
9	Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component 2009 ·Proceedings of the National Academy of Sciences ·Barry R. O’Keefe,Fakhrieh Vojdani,Viviana Buffa,Robin J. Shattock,David C. Montefiori,James Bakke,Jon C. Mirsalis,Annalisa D’Andrea,Steven D. Hume,Barry Bratcher,Carrie J. Saucedo,James B. McMahon,Gregory P. Pogue,Kenneth E. Palmer	208
10	Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine against Simian Immunodeficiency Virus Challenge in Rhesus Monkeys 2009 ·Journal of Virology ·Dan H. Barouch,Jinyan Liu,Diana M. Lynch,Kara L. O’Brien,Annalena La Porte,Nathaniel L. Simmons,(unknown),Sarah Clark,Peter Abbink,David C. Montefiori,Gary Landucci,Donald N. Forthal,Steven G. Self,Angela Carville,Keith G. Mansfield,Jaap Goudsmit	26
11	Increased Loss of CCR5 ⁺ CD45RA ⁻ CD4 ⁺ T Cells in CD8 ⁺ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys 2008 ·Journal of Virology ·Ronald S. Veazey,(unknown),(unknown),Susanne H.C. Baumeister,(unknown),Melisa D. Rett,Michael H. Newberg,Marcelo J. Kuroda,Kenneth C. Williams,Eun‐Young Kim,Steven M. Wolinsky,E. Peter Rieber,Michael Piatak,Jeffrey D. Lifson,David C. Montefiori,Charles R. Brown,Vanessa M. Hirsch,Jörn E. Schmitz	30
12	Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C 2008 ·Journal of Virology ·James Μ. Binley,(unknown),Emma T. Crooks,Michael S. Seaman,Elin S. Gray,Katie L. Davis,Julie M. Decker,Diane Wycuff,Linda Harris,Natalie Hawkins,Blake Wood,(unknown),Douglas D. Richman,Georgia D. Tomaras,Frédéric Bibollet‐Ruche,James E. Robinson,Lynn Morris,George M. Shaw,David C. Montefiori,John R. Mascola	278
13	Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIV _mac251 Challenge of Rhesus Macaques 2008 ·Journal of Virology ·Rachmat Hidajat,Peng Xiao,Qifeng Zhou,David Venzon,(unknown),Vaniambadi S. Kalyanaraman,David C. Montefiori,Marjorie Robert-Guroff	101
14	Neutralization-Sensitive R5-Tropic Simian-Human Immunodeficiency Virus SHIV-2873Nip, Which Carries env Isolated from an Infant with a Recent HIV Clade C Infection 2008 ·Journal of Virology ·Nagadenahalli B. Siddappa,Ruijiang Song,Victor G. Kramer,Agnès-Laurence Chenine,Vijayakumar Velu,Helena Ong,Robert A. Rasmussen,Ricky D. Grisson,Charles Wood,Hong Zhang,(unknown),Rama Rao Amara,James G. Else,Francis J. Novembre,David C. Montefiori,Ruth M. Ruprecht	32
15	Antiviral Antibodies Are Necessary for Control of Simian Immunodeficiency Virus Replication 2007 ·Journal of Virology ·Christopher J. Miller,Meritxell Genescà,Kristina Abel,David C. Montefiori,Donald N. Forthal,Kristen Bost,Jun Li,David Favre,Joseph M. McCune	64
16	Human Immunodeficiency Virus Type 1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction, and Potential for Regulation in Acute Infection 2007 ·Journal of Virology ·S. Munir Alam,Richard M. Scearce,Robert Parks,(unknown),(unknown),Laura L. Sutherland,Miroslaw K. Górny,Susan Zolla‐Pazner,(unknown),M. Anthony Moody,Shi-Mao Xia,David C. Montefiori,Georgia D. Tomaras,Kent J. Weinhold,Salim S. Abdool Karim,Charles B. Hicks,Hua‐Xin Liao,James E. Robinson,George M. Shaw,Barton F. Haynes	85
17	Heterologous Prime/Boost Immunization of Rhesus Monkeys by Using Diverse Poxvirus Vectors 2007 ·Journal of Virology ·Sampa Santra,Yue Sun,Jenny G. Parvani,Valérie Philippon,Michael S. Wyand,Kelledy Manson,(unknown),Gail P. Mazzara,Dennis Panicali,Phillip D. Markham,David C. Montefiori,Norman L. Letvin	36
18	Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys 2006 ·Science ·Norman L. Letvin,John R. Mascola,Yue Sun,Darci A. Gorgone,Adam P. Buzby,Ling Xu,Zhi-Yong Yang,Bimal K. Chakrabarti,Srinivas S. Rao,Jörn E. Schmitz,David C. Montefiori,Brianne R. Barker,Fred L. Bookstein,Gary J. Nabel	287
19	Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication 2004 ·Journal of Clinical Investigation ·David A. Garber,Guido Silvestri,Ashley P. Barry,Andrew Fedanov,Natalia Kozyr,Harold M. McClure,David C. Montefiori,Christian P. Larsen,John D. Altman,Silvija I. Staprans,Mark B. Feinberg	42
20	Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication 2004 ·Journal of Clinical Investigation ·David A. Garber,Guido Silvestri,Ashley P. Barry,Andrew Fedanov,Natalia Kozyr,Harold M. McClure,David C. Montefiori,Christian P. Larsen,John D. Altman,Silvija I. Staprans,Mark B. Feinberg	35

About David C. Montefiori

David C. Montefiori is a scholar working on Virology, Immunology and Infectious Diseases, having authored 616 papers that have together received 33.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (545 papers), Immune Cell Function and Interaction (240 papers) and HIV/AIDS drug development and treatment (116 papers). The work is most often cited by research in Virology (25.7k citations), Immunology (17.2k citations) and Infectious Diseases (11.1k citations). David C. Montefiori has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include John R. Mascola, Norman L. Letvin, Barton F. Haynes, Celia C. LaBranche, Miroslawa Bilska, Michael S. Seaman, Jörn E. Schmitz, William M. Mitchell, Sampa Santra and William E. Robinson. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact